Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR2DS4/CD158i Antibody (5F2), Biotin, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP104314B

Catalog No. NBP104314B


Only null left
Add to Cart

Description

Description

KIR2DS4/CD158i Monoclonal specifically detects KIR2DS4/CD158i in Human samples. It is validated for Western Blot, ELISA.
Specifications

Specifications

KIR2DS4/CD158i
Monoclonal
Biotin
PBS with 0.05% Sodium Azide
KIR2DS4
Recombinant human KIR2DS4/CD158i (23-223aa) purified from E. coli
0.1 mL
Immunology
3809
Human
Purified
Western Blot, ELISA
5F2
Western Blot, ELISA
CD158 antigen-like family member I, CD158I, CD158i antigen, cl-39, killer cell immunoglobulin-like receptor 2DS4, killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail4,nkat8, killer inhibitory receptor 4-1-2, KIR antigen 2DS4, KKA3KIR1D, MGC120019, MGC125315, MGC125317, MHC class I NK cell receptor, natural killer cell inhibitory receptor, Natural killer-associated transcript 8, NKAT-8, NKAT8KIR412, P58 natural killer cell receptor clones CL-39/CL-17, p58 NK receptor CL-39/CL-17
Mouse
Protein G purified
RUO
Primary
Anti-human KIR2DS4 mAb, clone 5F2, is derived from hybridization of mouse SP2/O myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human KIR2DS4 protein.
Store at 4C in the dark.
IgG2b κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.